Search details
1.
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
N Engl J Med
; 382(12): 1124-1135, 2020 03 19.
Article
in English
| MEDLINE | ID: mdl-32130806
2.
Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders.
Ann Hematol
; 101(10): 2281-2287, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35982337
3.
Correction to: Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit.
Infection
; 48(4): 521, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32435991
4.
Clinical and economic effects of an antimicrobial stewardship intervention in a surgical intensive care unit.
Infection
; 48(4): 509-519, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32277409
5.
Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
AIDS Res Ther
; 16(1): 34, 2019 11 15.
Article
in English
| MEDLINE | ID: mdl-31729999
6.
Correction to: Hemophagocytic lymphohistiocytosis in HIV-associated lymphoproliferative disorders.
Ann Hematol
; 102(7): 1971, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36795119
7.
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.
BMC Gastroenterol
; 17(1): 26, 2017 Feb 10.
Article
in English
| MEDLINE | ID: mdl-28187751
8.
Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.
Infection
; 44(2): 187-95, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26311655
9.
Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results.
J Infect Dis
; 208(1): 32-9, 2013 Jul.
Article
in English
| MEDLINE | ID: mdl-23532097
10.
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.
Antimicrob Agents Chemother
; 57(10): 4727-35, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23856779
11.
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease.
Blood
; 118(13): 3499-503, 2011 Sep 29.
Article
in English
| MEDLINE | ID: mdl-21778341
12.
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin.
J Hepatol
; 57(1): 39-46, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22414766
13.
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.
Gastroenterology
; 141(6): 2047-55; quiz e14, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21925126
14.
Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study.
Open Forum Infect Dis
; 8(9): ofab439, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34557563
15.
Source attribution of community-acquired cases of Legionnaires' disease-results from the German LeTriWa study; Berlin, 2016-2019.
PLoS One
; 15(11): e0241724, 2020.
Article
in English
| MEDLINE | ID: mdl-33237924
16.
Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
J Acquir Immune Defic Syndr
; 85(4): 498-506, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-33136751
17.
Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy.
Antivir Ther
; 14(5): 713-22, 2009.
Article
in English
| MEDLINE | ID: mdl-19704175
18.
Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96.
Antivir Ther
; 14(6): 859-64, 2009.
Article
in English
| MEDLINE | ID: mdl-19812449
19.
Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT).
Eur J Med Res
; 14(5): 195-9, 2009 May 14.
Article
in English
| MEDLINE | ID: mdl-19541575
20.
Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection.
Eur J Gastroenterol Hepatol
; 31(6): 723-728, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30964812